SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-064540
Filing Date
2021-11-15
Accepted
2021-11-15 17:59:52
Documents
1
Period of Report
2021-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3857
  Complete submission text file 0001209191-21-064540.txt   5437
Mailing Address 4401 WILSHIRE BLVD. SUITE 200 LOS ANGELES CA 90010
Business Address
ROYSTON IVOR (Reporting) CIK: 0001026765 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 211413073

Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations